BIOMAT Database Logo BIOMAT Database Logo

Corticosteroid therapy for chronic active hepatitis B: is a little to much? 1986

R P Perrillo, and F G Regenstein

UI MeSH Term Description Entries
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006521 Hepatitis, Chronic INFLAMMATION of the LIVER with ongoing hepatocellular injury for 6 months or more, characterized by NECROSIS of HEPATOCYTES and inflammatory cell (LEUKOCYTES) infiltration. Chronic hepatitis can be caused by viruses, medications, autoimmune diseases, and other unknown factors. Chronic Hepatitis,Cryptogenic Chronic Hepatitis,Hepatitis, Chronic, Cryptogenic,Hepatitis, Chronic Active,Hepatitis, Chronic Persistent,Chronic Active Hepatitis,Chronic Hepatitis, Cryptogenic,Chronic Persistent Hepatitides,Chronic Persistent Hepatitis,Hepatitis, Cryptogenic Chronic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000305 Adrenal Cortex Hormones HORMONES produced by the ADRENAL CORTEX, including both steroid and peptide hormones. The major hormones produced are HYDROCORTISONE and ALDOSTERONE. Adrenal Cortex Hormone,Corticoid,Corticoids,Corticosteroid,Corticosteroids,Cortex Hormone, Adrenal,Hormone, Adrenal Cortex,Hormones, Adrenal Cortex
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications

Related Publications

R P Perrillo, and F G Regenstein
Short-term corticosteroid therapy for chronic active hepatitis B.
January 1990, Digestion,
R P Perrillo, and F G Regenstein
Corticosteroid therapy for chronic active hepatitis.
October 1976, Annals of internal medicine,
R P Perrillo, and F G Regenstein
Corticosteroid therapy for chronic active hepatitis.
July 1984, The American journal of gastroenterology,
R P Perrillo, and F G Regenstein
Follow-up ten years after corticosteroid therapy for chronic active hepatitis type B.
April 1980, Hepato-gastroenterology,
R P Perrillo, and F G Regenstein
Sustained remission after corticosteroid therapy of severe hepatitis B surface antigen-negative chronic active hepatitis.
January 1987, Gastroenterology,
R P Perrillo, and F G Regenstein
[Corticosteroid withdrawal therapy for hepatitis B].
October 1995, Nihon rinsho. Japanese journal of clinical medicine,
R P Perrillo, and F G Regenstein
Controlled prospective trial of corticosteroid therapy in active chronic hepatitis.
April 1971, The Quarterly journal of medicine,
R P Perrillo, and F G Regenstein
How much hepatitis B is too much?
June 2003, The American journal of gastroenterology,
R P Perrillo, and F G Regenstein
Effect of corticosteroid therapy on bromsulphthalein excretion in active chronic hepatitis.
June 1968, Gut,
R P Perrillo, and F G Regenstein
Bone loss in autoimmune chronic active hepatitis on maintenance corticosteroid therapy.
November 1985, Gastroenterology,
Copied contents to your clipboard!